T-E pharma focuses on the research, development, and commercialization of a class of new drugs, which are created based on proprietary technology platform, for treating multiple types of cancer, a number of severe indications in autoimmune, osteoporosis, infectious, and central nervous system diseases, pathological blood clots, rejection reaction in organ transplantation, and other selected severe clinical conditions.